Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment

Immunoregulatory vaccine

OX40L fusion protein for the immunotherapy of tumors of veterinary animals

Toll-like receptors

Polypeptides and immunizing compositions containing polypeptides and methods of use

COMPOSITIONS AND METHODS FOR ENHANCING ANTIGEN-SPECIFIC IMMUNE RESPONSES

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle vaccine

Multimeric fusion protein vaccine and immunotherapeutic

Detoxified endotoxin immunogenic compositions and uses thereof

Nanoparticles for treatment of allergy

Chiral nucleic acid adjuvant

Conjugates for the Prevention or Treatment of Nicotine Addiction

Materials and methods for modulating immune responses

Oil-based adjuvants

Compositions for stimulation of mammalian innate immune resistance to pathogens

Methods and compositions involving immunostimulatory oligodeoxynucleotides

Immunotherapy against several tumors including neuronal and brain tumors

IgE CH3 peptide vaccine

NEGATIVELY CHARGED NUCLEIC ACID COMPRISING COMPLEXES FOR IMMUNOSTIMULATION

Modified coiled coil type proteins having improved properties

Immunostimulatory oligonucleotides

Mesoporous silica compositions for modulating immune responses

IMMUNOSTIMULATORY COMPOSITIONS, PARTICLES, AND USES RELATED THERETO

Compositions and methods for activating stimulator of interferon gene-dependent signalling

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

N-domain of carcinoembryonic antigen and compositions, methods and uses thereof

ANTI-TUMOR COMPOSITIONS AND USES THEREOF

Malaria vaccine

Packaging of immunostimulatory substances into virus-like particles: method of preparation and use

Long term disease modification using immunostimulatory oligonucleotides

Combination therapy using active immunotherapy

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

Computationally optimized broadly reactive antigens for H5N1 and H1N1 influenza viruses

Compositions and methods for cancer immunotherapy

Tuberculosis compositions and methods of using the same

Compositions and methods for treating influenza

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

NOVEL DOUBLE-STRANDED RIBONUCLEIC ACIDS WITH RUGGED PHYSICO-CHEMICAL STRUCTURE AND HIGHLY SPECIFIC BIOLOGIC ACTIVITY

Compositions including β-glucans and methods of use

Immunogenic composition comprising Panton-Valentine Leukocidin (PVL) derived polypeptides

Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors

Stabilized mosaic human immunodeficiency virus type 1 (HIV-1) GP140 envelope (ENV) trimers

Influenza virus-like particle (VLP) compositions

Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity

Combination adjuvant formulation

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

Programming of cells for tolerogenic therapies

Injectable cryogel vaccine devices and methods of use thereof

Immunostimulatory oligodeoxynucleotides

Immunostimulatory oligodeoxynucleotides

In situ antigen-generating cancer vaccine

Immunomodulatory agent-polymeric compounds

Chimeric immunomodulatory compounds and methods of using the same-IV

Biodegradable particulate formulations

Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration

Allogeneic autophagosome-enriched composition for the treatment of disease

Method of developing a vaccine using peptide-poly IC complexes

Vaccine

Pneumococcal vaccine and uses thereof

Deletion of the beta 20-21 loop in HIV GP120 exposes the CD4 binding site for improved antibody binding and antibody induction

Chlamydia antigens

Adjuvant compositions

CyaA-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses

Vaccines directed to langerhans cells

Immunogenic compositions

Parovirus having a CpG-enriched genome useful for cancer therapy

Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

Conjugated β-1,3-linked glucans

Lipid-polymer hybrid particles

Vaccines for inclusion body hepatitis

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

Vaccine composition

Methods and compositions to produce vaccines against smallpox in plants

Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies

Vaccine immunotherapy

Method for preparing liposome-based constructs

Immunogenic compositions comprising polypeptides and fusions thereof

Controlled delivery of TLR agonists in structural polymeric devices

Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity

Vaccine delivery method

Nucleic acid having adjuvanticity and use thereof

Nano-vehicle derived from tumor tissue, and cancer vaccine using same

Chimeric adenoviral vectors

Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation

Nucleic acid comprising GXGas an immune-stimulating agent/adjuvant

Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant

Immunotherapy comprising TLR9 ligand and CD40 ligand

Compositions and methods for treating influenza

Homogenous suspension of immunopotentiating compounds and uses thereof

Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules

N-domain of carcinoembryonic antigen and compositions, methods and uses thereof

(POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE

Mucosal vaccines

Viral Immunogenic Compositions

ADJUVANT CONTAINING beta-HEMATIN

HERPES SIMPLEX VIRUS COMBINED SUBUNIT VACCINES AND METHODS OF USE THEREOF

Activation of RIG-I Pathway

Methods and compositions for modulating an immune response with immunogenic oligonucleotides

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

IMMUNOGENIC COMPOSITIONS USEFUL IN PROVOKING AN INTEGRATED RESPONSE TO TUMOR ANTIGENS

INHIBITORS OF LL-37 MEDIATED IMMUNE REACTIVITY TO SELF NUCLEIC ACIDS

RSV IMMUNOGENS, ANTIBODIES AND COMPOSITIONS THEREOF

1C31 nanoparticles

DNA vaccines and methods for the prevention of transplantation rejection

Packaging of immunostimulatory substances into virus-like particles: method of preparation and use

VACCINE AGAINST NEOPLASTIC OR CANCEROUS LESIONS CAUSED BY HUMAN PAPILLOMA VIRUS (HPV), PROCEDURES, USES AND METHODS

STABLE IMMUNOGENIC PROTEIN HAVING MULTIPLE CYSTEINES MOLECULES PROCESS THEREFOR AND COMPOSITION THEREOF

Methods and compositions for eliciting an immune response against hepatitis B virus

Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines

Use of an L3 and/or L5 source as a vaccine or as a diagnostic for a parasitic disease

RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles

HEPATITIS C VIRUS VACCINE COMPOSITION

Compositions and methods for preventing or treating infection

IMMUNIZATION STRATEGY TO PREVENT H1N1 INFECTION

Therapeutic Compositions For The Treatment of HPV-Induced Diseases

Chimeric immunomodulatory compounds and methods of using the same-IV

Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides

Formulation of drugs and vaccines in the form of percutaneous injectable needles

COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY

COMBINATION THERAPY FOR IMMUNOSTIMULATION

Immunostimulatory oligonucleotides

Efficient mucosal vaccination mediated by the neonatal Fc receptor

Transcutaneous immunization without heterologous adjuvant

Peptide, adjuvants, vaccines, and methods of use

Compositions and methods to treat and control tumors

Method of inducing neutralizing antibodies to human immunodeficiency virus

Stabilized immune modulatory RNA (SIMRA) compounds

FORMULATION

COMPOSITIONS COMPRISING IMMUNOSTIMULATORY NUCLEIC ACIDS AND RELATED METHODS

MUCOSAL BOOSTING FOLLOWING PARENTERAL PRIMING

RSV F PROTEIN COMPOSITIONS AMD METHODS FOR MAKING SAME

Methods for preparing vesicles and formulations produced therefrom

Immunomodulatory compositions comprising a polymer matrix and an oil phase

Immunotherapy against several tumors including neuronal and brain tumors

Oral Vaccines for Producing Mucosal Immunity

CHLAMYDIA ANTIGENS AND USES THEREOF

Scaffolds for cell transplantation

Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositions

RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles

HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS

COMPOSITIONS AND METHODS FOR IMMUNOSTIMULATORY RNA OLIGONUCLEOTIDES

Programming of cells for tolerogenic therapies

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

Immunogenic compositions containing phospholipid

SYNERGISTIC TREATMENT OF CANCER USING IMMUNOMERS IN CONJUNCTION WITH CHEMOTHERAPEUTIC AGENTS

Continuous cell programming devices

NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

Chlamydia antigens

Compositions for stimulation of mammalian innate immune resistance to pathogens

Method for prophylaxis of influenza using vaccine for intranasal administration

Malaria vaccine

CASB7439 constructs

ENHANCED IMMUNE RESPONSE IN AVIAN SPECIES

Vaccine immunotherapy

Lipids and compositions for the delivery of therapeutics

Adenovirus vectors

PNEUMOCOCCAL VACCINE AND USES THEREOF

Agonists of toll-like receptor 3 and methods of their use

Dose selection of adjuvanted synthetic nanocarriers

Lipids and compositions for the delivery of therapeutics

Nucleic acids comprising formula (NGXGN)and derivatives thereof as immunostimulating agent/adjuvant

Vaccines comprising TB10.4

MODULATION OF THE IMMUNE RESPONSE

Double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity

Compostition and therapeutic anti-tumour vaccine

Olioodeoxynucleotide and its use to induce an immune response

Lipids and compositions for the delivery of therapeutics

Lipids and compositions for the delivery of therapeutics

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS

Conjugates for the prevention or treatment of nicotine addiction

HCV VACCINES

IMMUNOSTIMULATORY DNA:RNA OLIGONUCLEOTIDES

IgE CH3 peptide vaccine

SYSTEMS AND METHODS FOR ENHANCING VACCINE EFFICACY

SYNTHETIC NANOCARRIER COMBINATION VACCINES

Compounds and methods for the treatment of inflammatory diseases of the CNS

MULTIVALENT SYNTHETIC NANOCARRIER VACCINES

NANOCARRIER COMPOSITIONS WITH UNCOUPLED ADJUVANT

In Vivo Activation of Antigen Presenting Cells for Enhancement of Immune Responses Induced by Virus Like Particles

USE OF A SACCHAROMYCES CEREVISIAE MITOCHONDRIAL NUCLEIC ACIDS FRACTION FOR IMMUNE STIMULATION

MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS

Increased Expression of Specific Antigens

PRODUCTS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE

IMMUNOSTIMULATORY COMBINATIONS

Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells

Polynucleotides that stimulate neutrophils

USE OF PHENOL-SOLUBLE MODULINS FOR VACCINE DEVELOPMENT

COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT OF HBV INFECTIONS AND HBV-MEDIATED DISEASES

Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof

METHOD OF USING TUMOR CELL DEBRIS TO REDUCE BRAIN TUMOR RECURRENCE OR GROWTH

MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM

Herpes simplex virus combined subunit vaccines and methods of use thereof

IMMUNOSTIMULATING SAPONINS FOR USE IN SITU TUMOR-DESTRUCTION THERAPY

VACCINE ADJUVANT COMBINATIONS

Bluetongue virus recombinant vaccines and uses thereof

FOOT AND MOUTH DISEASE VIRUS RECOMBINANT VACCINES AND USES THEREOF

Bacterial Polysaccharide-Polypeptide Conjugate Compositions

Acid-degradable and bioerodible modified polyhydroxylated materials

Lipid vesicle compositions and methods of use

COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends

dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants

Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies

Oligodeoxynucleotide and its use to induce an immune response

Inactivated chimeric vaccines and related methods of use

Immunogenic substances comprising a polyinosinic acid—polycytidilic acid based adjuvant

Immunostimulatory oligoribonucleotides

SEMI-SOFT C-CLASS IMMUNOSTIMULATORY OLIGONUCLEOTIDES

Multivalent antihelminthic vaccine

Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration

Multiple CpG oligodeoxynucleotide and their use to induce an immune response

Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof

Use of inhibitory oligonucleotides to treat autoimmune disease

ADJUVANTED INFLUENZA VACCINES INCLUDING CYTOKINE-INDUCING AGENTS

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A

COMPOSITIONS COMPRISING CATIONIC MICROPARTICLES AND HCV E1E2 DNA AND METHODS OF USE THEREOF

Vaccines for inclusion body hepatitis

Vaccine

METHODS OF TREATING AND PROTECTING AGAINST HUMAN IMMUNODEFICIENCY VIRUS

SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY

Compositions, Methods, and Kits for Eliciting an Immune Response

BIOACTIVE PURIFIED HSPE7 COMPOSITIONS

Membrane proximal region of HIV gp41 anchored to the lipid layer of a virus-like particle vaccine

METHODS AND PRODUCTS RELATED TO TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION

Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy

Use of mTOR inhibitors to enhance T cell immune responses

POTENT MUCOSAL IMMUNE RESPONSE INDUCED BY MODIFIED IMMUNOMODULATORY OLIGONUCLEOTIDES

Methods and compositions for immunization against chlamydial infection and disease

Long term disease modification using immunostimulatory oligonucleotides

Immunologically active compositions

USE OF IMMUNOGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF PATHOGEN INFECTIONS

NON-DNA BASE-CONTAINING POLYNUCLEOTIDE COMPOSITIONS AND THEIR USE FOR THE MODULATION OF IMMUNE RESPONSES

METHOD AND VACCINE FOR OPTIMIZING THE SPECIFIC IMMUNE RESPONSES

Multiclade HIV Vaccines

MUTANT FORMS OF CHLAMYDIA HTRA

SYNERGISTIC INDUCTION OF HUMORAL AND CELLULAR IMMUNITY BY COMBINATORIAL ACTIVATION OF TOLL-LIKE RECEPTORS

Use of toll-like receptor ligands as adjuvants to vaccination therapy for brain tumors

Immune stimulatory oligonucleotide analogs containing modified sugar moieties

COMPOSITIONS AND METHODS FOR TREATING INFLUENZA

MELAN-A-CARRIER CONJUGATES

Schistosomiasis vaccine compositions and methods of use

Vaccine compositions

Compositions and methods for preventing or treating a viral infection

Chimeric adenoviral vectors

Protein vaccines against poxviruses

IMMUNOSTIMULATORY NUCLEIC ACID MOLECULES

VACCINES DIRECTED TO LANGERHANS CELLS

Compositions Comprising Liposomes, An Antigen, A Polynucleotide and A Carrier Comprising a Continuous Phase of a Hydrophobic Substance

PACKAGED VIRUS-LIKE PARTICLES FOR USE AS ADJUVANTS: METHOD OF PREPARATION AND USE

IMMUNOGENIC COMPOSITIONS FOR CHLAMYDIA TRACHOMATIS

Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use

Viral adjuvants

Formulation for room temperature stabilization of a live attenuated bacterial vaccine

Preventing and treating amyloid-beta deposition by stimulation of innate immunity

Lyophilised antigen composition

MODULATION OF OLIGONUCLEOTIDE CPG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES

Adjuvant comprising aluminum, oligonucleotide and polycation

HYBRID POLYPEPTIDES COMPRISING GBS-80 AND SPB1 PROTEINS OF STREPTOCOCCUS

VACCINES INCLUDING ANTIGEN FROM FOUR STRAINS OF INFLUENZA VIRUS

Conjugated beta-1,3-linked glucans

Helper Virus-Free Herpesvirus Amplicon Particles and Uses Thereof

ADJUVANT COMPOSITIONS COMPRISING POLY-IC AND A CATIONIC POLYMER

Inhibitors of DNA Immunostimulatory Sequence Activity

REAGENTS FOR INDUCING AN IMMUNE RESPONSE

Anti-infective agents and uses thereof

Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids

Parvovirus having a CPG-enriched genome useful for cancer therapy

METHODS RELATED TO IMMUNOSTIMULATORY NUCLEIC ACID-INDUCED INTERFERON

RNA Vaccines

Immunomodulatory agent-polymeric compounds

VACCINE COMPRISING A RIBOSOMAL PROTEIN EXTRACT (RPE) AND OPTIONALLY A TH1-PROMOTING ADJUVANT

TARGETED SYNTHETIC NANOCARRIERS WITH PH SENSITIVE RELEASE OF IMMUNOMODULATORY AGENTS

HIV COMBINATION VACCINE AND PRIME BOOST

METHODS AND MEANS FOR THE TREATMENT OF HPV INDUCED INTRAEPITHELIAL NEOPLASIAS

Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers

Ex vivo uses of immunostimulatory combinations

BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION

IMMUNOSTIMULATORY OLIGORIBONUCLEOTIDES

Vectors and method for genetic immunization

Chimeric HIV-1 Glycoproteins and Their Biological Applications

IMMUNOSTIMULATION BY CHEMICALLY MODIFIED RNA

NANOCARRIERS POSSESSING COMPONENTS WITH DIFFERENT RATES OF RELEASE

Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity

Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine

Polyinosinic acid-polycytidylic acid-based adjuvant

Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid molecule

Immunostimulatory combinations of TLR ligands and methods of use

Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection

Method of providing patient specific immune response in amyloidoses and protein aggregation disorders

Immunomodulatory compositions, formulations, and methods for use thereof

IMMUNOTHERAPY COMPOSITIONS, METHOD OF MAKING AND METHOD OF USE THEREOF

MULTICOMPONENT VACCINE

Class A Oligonucleotides with Immunostimulatory Potency

RNA sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles

Vaccine for viruses that cause persistent or latent infections

VACCINES

ADJUVANTED GLUCANS

Immunogenic compositions for chlamydia trachomatis